Drug
Ad4 H5 Vtn
Ad4 H5 Vtn: highest development phase Phase 1, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ad4-H5-Vtn NCT01006798 | Phase 1 | Bird Flu |
Latest
No recent events.
Follow Ad4 H5 Vtn on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.